MedTest DX has acquired the entire portfolio of chemistry products from Polymedco, manufacturer and supplier of diagnostic test kits and instruments for the clinical laboratory.
The acquisition includes the SPOTCHEM EZ benchtop chemistry analyzer and associated reagents, Poly-Chem chemistry analyzer and its related reagents and bulk chemistry reagents. The purchase took place on April 20th, 2011.
MedTest, located in Cortlandt Manor, New York, was formed in 2011 as part of the acquisition of Polymedco’s chemistry assets. Through the U.S. distribution network, the company will market reagents, chemistry instruments and services to research facilities, reference laboratories, hospitals and physician offices. Enhanced Equity Fund, a private equity firm, has invested in MedTest.
MedTest’s CEO, James White stated that he is happy to work with Polymedco’s team and Drew Cervasio, Polymedco’s President. The purchase will help MedTest to develop its chemistry business and build good reputation in the market.